氯沙坦对冠心病患者血清sICAM-1,sVCAM-1水平的影响
出处
《心脏杂志》
CAS
2003年第6期575-576,共2页
Chinese Heart Journal
参考文献4
-
1[1]O'Brien KD,McDonald TO,Chait A,et al. Neovascular expression of E-selectin,intercellular adhesion molecular-1,and vascular cell adhesion molecular-1 in human artherosclerosis and their relation to intimal leukocyte content[J]. Circulation,1996,93:672-682.
-
2[2]John S,Jacobi J,Delles C,et al. Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis[J]. Clin Sci(Colch)2000,98(5):521-529.
-
3[3]Pueyo ME,Gonzalez W,Nicoletti A,et al. Angitensin Ⅱ stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress[J]. Arterioscler Thromb Vasc Biol,2000,20(3):645-651.
-
4[4]Hoshida S,Nishida M,Yamashita N,et al. Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits:effects of enalapril[J]. Atherosclerosis,1997,130(1-2):53-59.
-
1强华琼.氯沙坦联合氨氯地平治疗老年高血压合并糖尿病的临床疗效[J].实用心脑肺血管病杂志,2014,22(3):77-78. 被引量:16
-
2彭茜苑,曾小丽,梁淑慧.氯沙坦治疗50例慢性肺心病并发心力衰竭的护理[J].齐齐哈尔医学院学报,2005,26(2):208-209.
-
3易斌,刘群峰.科素亚治疗慢性充血性心力衰竭疗效观察[J].医学理论与实践,2002,15(5):536-537. 被引量:1
-
4廖静,林建华.氯沙坦和福辛普利降压、降尿酸作用的临床观察[J].四川医学,2009,30(2):234-235. 被引量:1
-
5蔡磊,陈平,王金委.氯沙坦钾与螺内酯治疗慢性心力衰竭124例临床分析[J].温州医学院学报,2013,43(4):273-274. 被引量:4
-
6王利芳,杨丽君.氯沙坦对慢性心力衰竭患者血清尿酸水平的影响[J].实用心脑肺血管病杂志,2010,18(1):34-35. 被引量:3
-
7武彩云.氯沙坦对肝硬化门静脉高压患者血清TXA2、PGE2、TNF2A浓度的影响[J].内蒙古中医药,2011,30(16):1-2.
-
8辛藏玲,宁东艳.黄芪注射液联合氯沙坦治疗早期糖尿病肾病64例疗效观察[J].中国煤炭工业医学杂志,2005,8(11):1191-1192.
-
9汤宝鹏,杨毅宁,马依彤,程祖亨,张爱伦,孙慧萍,张燕一.氯沙坦和倍他乐克对急性心肌梗死患者左心室重塑的影响[J].新疆医科大学学报,2003,26(5):424-426. 被引量:1
-
10陈湛生,刘苏陵.氯沙坦对充血性心力衰竭远期预后的影响[J].中国心血管病研究,2004,2(2):113-115. 被引量:4